Secondary porphyrias not due to an inherited biochemical defect in heme synthesis can be distinguished from true porphyrias by measuring levels of

• A. Urinary ALA and PBG
• B. Urinary COPRO and blood lead
• C. Urinary URO and COPRO
• D. Fecal URO and urinary COPRO

Answer: (A)

The key idea is that true porphyrias arise from inherited defects in the early steps of heme synthesis, causing buildup of the initial pathway intermediates. When a block occurs early, precursors like delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) accumulate and are excreted in urine. Measuring urinary ALA and PBG therefore directly reflects this upstream block and helps distinguish inherited porphyrias from secondary ones, where the disturbance is downstream or due to external factors and early precursors may not be elevated.

Urinary ALA and PBG are elevated in true porphyrias because the defective enzyme halts the pathway soon after ALA formation, leading to backup of these early products. In secondary porphyrias, the problem isn’t a genetic block in the initial steps, so these early intermediates aren’t characteristically high, even though porphyrins downstream may accumulate.

The other options look at later-appearing porphyrins or non-specific markers. Coproporphyrin and uroporphyrin levels can rise in various porphyrias and conditions, including secondary ones, so they don’t reliably separate inherited defects from secondary dysfunction. Similarly, fecal and urinary measurements of different porphyrins don’t provide the same diagnostic distinction as the early precursors ALA and PBG.